Irani Soussan
Dental Research Center, Dept. of Oral and Maxillofacial Pathology, School of Dentistry, Hamadan University of Medical Sciences, Hamadan, Iran. and Lecturer at Griffith University, Gold Coast, Australia.
J Dent (Shiraz). 2016 Jun;17(2):71-83.
Head and neck cancers include epithelial tumors arising in the oral cavity, pharynx, larynx, paranasal sinuses, and nasal cavity. Metastasis is a hallmark of cancer. MicroRNAs (miRNAs) are endogenous small non-coding RNAs involved in cell proliferation, development, differentiation and metastasis. It is believed that miRNA alterations correlate with initiation and progression of cancer cell proliferation or inhibition of tumorigenesis. Moreover, miRNAs have different roles in development, progression, and metastasis of head and neck squamous cell carcinoma (HNSCC). Altered expression of miRNAs could be novel molecular biomarkers for the definite diagnosis of cancer, metastatic site, cancer stage, and its progression.
The purpose of this review was to provide a comprehensive literature review of the role of miRNAs in head and neck cancer metastasis.
A relevant English literature search in PubMed, ScienceDirect, and Google Scholar was performed. The keywords 'miRNA', 'head and neck', and 'cancer' were searched in title and abstract of publications; limited from 1990 to 2015. The inclusion criterion was the role of miRNAs in cancer metastasis. The exclusion criterion was the other functions of miRNAs in cancers. Out of 15221 articles, the full texts of 442 articles were retrieved and only 133 articles met the inclusion criteria.
Despite the advances in cancer treatment, the mortality rate of HNSCC is still high. The potential application of miRNAs for cancer therapy has been demonstrated in many studies; miRNAs function as either tumor suppressor or oncogene. The recognition of metastamir and their targets may lead to better understanding of HNSCC oncogenesis, and consequently, development of new therapeutic strategies which is a necessity in cancer treatment. Development of therapeutic agents based on miRNAs is a promising target.
头颈癌包括起源于口腔、咽、喉、鼻窦和鼻腔的上皮性肿瘤。转移是癌症的一个标志。微小RNA(miRNA)是参与细胞增殖、发育、分化和转移的内源性小非编码RNA。据信,miRNA改变与癌细胞增殖的起始和进展或肿瘤发生的抑制相关。此外,miRNA在头颈部鳞状细胞癌(HNSCC)的发生、发展和转移中具有不同作用。miRNA表达改变可能成为癌症确诊、转移部位、癌症分期及其进展的新型分子生物标志物。
本综述的目的是对头颈部癌转移中miRNA的作用进行全面的文献综述。
在PubMed、ScienceDirect和谷歌学术上进行了相关英文文献检索。在出版物的标题和摘要中搜索关键词“miRNA”、“头颈部”和“癌症”;检索时间限制为1990年至2015年。纳入标准是miRNA在癌症转移中的作用。排除标准是miRNA在癌症中的其他功能。在15221篇文章中,检索到442篇文章的全文,只有133篇文章符合纳入标准。
尽管癌症治疗取得了进展,但HNSCC的死亡率仍然很高。许多研究已证明miRNA在癌症治疗中的潜在应用;miRNA既可以作为肿瘤抑制因子,也可以作为癌基因发挥作用。对转移相关miRNA及其靶点的认识可能有助于更好地理解HNSCC的肿瘤发生机制,从而开发新的治疗策略,这是癌症治疗的必要手段。基于miRNA开发治疗药物是一个有前景的目标。